EPDR1 Links Fibroblast Dysfunction to Disease Severity in Idiopathic Pulmonary Fibrosis
Cells · 2025
DOI: 10.3390/cells14191515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Jong-Uk Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Program in Biomedical Science Major, Soonchunhyang Graduate School, Bucheon 14584, Republic of Korea. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Fibroblasts. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by aberrant fibroblast activation, lysosomal dysfunction, and cellular senescence. Transcriptomic analyses have identified ependymin-related 1 (EPDR1) as a fibroblast-enriched gene in IPF, but its biological function remains unclear. EPDR1 expression was assessed in lung fibroblasts, lung tissues, bronchoalveolar lavage fluid (BALF), and serum from IPF patients and controls using qPCR, Western blotting, ELISA, and immunohistochemistry. Lysosomal function, autophagic flux, and senescence markers were analyzed in primary fibroblasts following siRNA-mediated EPDR1 knockdown. EPDR1 was significantly upregulated in IPF-derived fibroblasts and localized to fibrotic regions enriched with α-SMA+, COL1A1+, and FN1+ myofibroblasts of IPF-derived lung tissues. EPDR1 levels were markedly elevated in the BALF and serum of IPF patients and correlated with increased mortality. IPF fibroblasts exhibited reduced lysosomal acidification and impaired autophagic flux, indicated by p62 and LC3B accumulation. EPDR1 knockdown restored lysosomal function; enhanced autophagic degradation; and reduced senescence markers, including p21, p16, and SA-β-gal activity. EPDR1 drives lysosomal dysfunction and fibroblast senescence in IPF. Its elevated expression in lung tissue and biological fluids, together with its association with prognosis, highlights EPDR1 as a potential biomarker and therapeutic target in IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interdisciplinary Program in Biomedical Science Major, Soonchunhyang Graduate School, Bucheon 14584, Republic of Korea.
- Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon 14584, Republic of Korea.
- Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul 04401, Republic of Korea.
- Department of Microbiology, College of Medicine, Soonchunhyang University, Cheonan 33151, Republic of Korea.
ORCID-Profile: Jong-Uk Lee, Seung-Lee Park, Min Kyung Kim, Eunjeong Seo, Hun-Gyu Hwang, Hun Soo Chang, Choon-Sik Park
Förderung
- Ministry of Education
Zitieren
APA
Lee, J. U., Park, S. L., Kim, M. K., Seo, E., Hwang, H. G., Kim, J. H., Chang, H. S., & Park, C. S. (2025). EPDR1 Links Fibroblast Dysfunction to Disease Severity in Idiopathic Pulmonary Fibrosis. Cells. https://doi.org/10.3390/cells14191515
Vancouver
Lee JU, Park SL, Kim MK, Seo E, Hwang HG, Kim JH, et al. EPDR1 Links Fibroblast Dysfunction to Disease Severity in Idiopathic Pulmonary Fibrosis. Cells. 2025. doi:10.3390/cells14191515
BibTeX
@article{Lee2025,
author = {Lee, Jong-Uk and Park, Seung-Lee and Kim, Min Kyung and Seo, Eunjeong and Hwang, Hun-Gyu and Kim, Jung Hyun and Chang, Hun Soo and Park, Choon-Sik},
title = {EPDR1 Links Fibroblast Dysfunction to Disease Severity in Idiopathic Pulmonary Fibrosis},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14191515}
}
EUVIMED